Deutsche Bank analyst George Hill lowered the firm’s price target on Definitive Healthcare to $5 from $7 and keeps a Hold rating on the shares post the Q2 report.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DH:
- Definitive Healthcare price target lowered to $5 from $6 at Baird
- Definitive Healthcare price target lowered to $4 from $6 at Barclays
- Definitive Healthcare price target lowered to $5 from $9 at Morgan Stanley
- Definitive Healthcare price target lowered to $6 from $8 at Canaccord
- Definitive Healthcare backs FY24 adjusted EPS view 32c-34c, consensus 34c